Gene Expression Oncology Reference Lab Testing for VISN19 36C259-25-AP-1137
Summary
AI-generated · Nov 06, 2025Seeking potential sources capable of providing Oncotype gene expression reference laboratory testing services for VISN 19, including specimen preparation and storage, transportation of clinical specimens, analytical testing, reporting of results, and consultative services. The provider must be approved to perform clinical diagnostic laboratory tests under Medicare and Medicaid regulations and all applicable federal and state laws, and capable of offering the listed tests or their equivalents: Oncotype DX Breast Recurrence Score Assay (81519); Oncotype DX Breast DCIS Score Assay (0045U); Oncotype DX Colon Recurrence Score Assay (81525); Oncoguard Liver CPT (81599); OncoExtra (0329U); and Cologuard CPT (81528).
The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing Oncotype Genetic (Gene Expression) Reference Lab Testing Services (or equivalent) that includes but is not limited to: specimen preparation and storage; transportation of clinical laboratory specimens; performance of analytical testing; reporting of analytical test results; and consultative services. The Contractor shall be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and all applicable federal and state laws. The Contractor shall be capable of providing the following gene expression tests (OR EQUIVALENT): a) Oncotype DX Breast Recurrence Score Assay (81519); b) Oncotype DX Breast DCIS Score Assay (0045U); c) Oncotype DX Colon Recurrence Score Assay (81525): d) Oncoguard Liver CPT (81599); e) OncoExtra (0329U); and f) Cologuard CPT (81528)
From Sources Sought posted on Nov 05, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA